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Summary 
This report complements Expenditure on health for Aboriginal and Torres Strait Islander people 
2010–11 (AIHW 2013a) by providing a more detailed analysis of health expenditure 
estimates for Indigenous and non-Indigenous Australians in 2010–11. Estimates are 
disaggregated at the regional level, as well as for specific disease and injury groups. 
Health expenditure by remoteness 
Expenditure was analysed for selected health services (i.e. admitted patients, Aboriginal 
Community Controlled Health Services, Medicare Benefits Schedule and Pharmaceutical 
Benefits Scheme). For these services, for every dollar spent per non-Indigenous Australian, 
$1.52 was spent per Indigenous Australian and expenditure increased with remoteness for 
both Indigenous and non-Indigenous Australians.  
The difference was greatest in Remote/Very remote areas where, for every dollar spent per 
non-Indigenous Australian, $2.22 was spent per Indigenous Australian. The higher 
expenditure on Aboriginal and Torres Strait Islander people in remote areas is mainly due to 
higher expenditure on admitted patient services. 
Health expenditure by disease group 
The disease groups that accounted for the highest proportion of admitted patient 
expenditure for Aboriginal and Torres Strait Islander people were genitourinary diseases 
($195 million, or 11% of Indigenous admitted patient expenditure), which includes the cost of 
dialysis treatment, followed by mental and behavioural disorders ($191 million or 11%), 
unintentional injuries ($149 million or 8%) and maternal conditions ($144 million or 8%). 
The largest disease group of admitted patient expenditure for non-Indigenous Australians 
was cardiovascular disease ($5,171 million, or 12% of non-Indigenous admitted patient 
expenditure). 
Potentially preventable hospitalisations  
Overall, for every dollar spent on potentially preventable hospitalisations (PPH) per non-
Indigenous Australian, $2.22 was spent per Indigenous Australian.  
The highest expenditure on PPH for Indigenous Australians was for chronic obstructive 
pulmonary disease ($36 million, or 16% of Indigenous PPH expenditure), followed by 
diabetes complications ($35 million or 16%) and cellulitis ($20 million or 9%). Expenditure on 
vaccine-preventable conditions was $21 per Indigenous Australian and $5 per non-
Indigenous Australian. 
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1 Introduction 
This report builds on the national and state level estimates published in Expenditure on health 
for Aboriginal and Torres Strait Islander people 2010–11 (AIHW 2013a). It provides estimates at 
the regional level as well as for specific disease and injury groups.  
Expenditure on health for Aboriginal and Torres Strait Islander people 2010–11 showed that the 
estimated per person expenditure on health services for Indigenous Australians in 2010–11 
was 1.47 times that for the non-Indigenous population. There is, however, considerable 
variation in health expenditure for Aboriginal and Torres Strait Islander people across 
regions, service types and disease groups that is not well reflected by the Australia-wide 
ratio. 
This report provides a more detailed examination of how health services for Aboriginal and 
Torres Strait Islander people are delivered and used. It focuses on how Indigenous health 
expenditure varies by location and how expenditure on particular diseases differs between 
Indigenous and non-Indigenous people. 
The effect of location on expenditure 
As noted in Expenditure on health for Aboriginal and Torres Strait Islander people 2010–11, while 
more than half (54.3%) of Australia’s Aboriginal and Torres Strait Islander people live in 
Major cities and Inner regional areas, a large proportion (23.3%) reside in Remote/Very remote 
areas. In comparison, only 1.7% of non-Indigenous Australians reside in Remote/Very remote 
areas.  
Economies of scale and the relative isolation of some Aboriginal and Torres Strait Islander 
populations can affect the cost of delivering health goods and services. These factors can 
have large impacts on both the levels of health expenditure and the quantity of goods and 
services provided to particular population groups.  
This report presents expenditure estimates by Australian Standard Geographical 
Classification (ASGC) remoteness areas. 
Disease expenditure 
Aboriginal and Torres Strait Islander people are hospitalised at a higher rate than non-
Indigenous Australians, as well as being hospitalised for particular conditions at higher rates 
than non-Indigenous Australians (AIHW 2012a).  
As reported in Expenditure on health for Aboriginal and Torres Strait Islander people 2010–11, 
expenditure per Indigenous Australian in public hospitals was more than twice that for non-
Indigenous Australians.  
This report provides an analysis of expenditure in public and private hospitals by presenting 
expenditure for particular disease and injury groups, including potentially preventable 
hospitalisations (PPH).  
These estimates enable monitoring of expenditure on the conditions for which Indigenous 
people access hospital services. However, in this context it should be noted that expenditure 
is not a direct measure of the size of the disease burden on the Aboriginal and Torres Strait 
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Islander population. Expenditure is influenced by service availability and use, disease 
prevalence and severity, and treatment requirements. 
Data sources and methods  
The health expenditure estimates by remoteness presented in this report are derived from 
the Australian Institute of Health and Welfare’s (AIHW’s) Health expenditure database, 
which is compiled annually from a wide range of government and non-government sources. 
These data sources include:  
• Australian Government Department of Health and Ageing (DoHA) 
• Australian Bureau of Statistics 
• Australian Government Department of Veterans’ Affairs  
• state and territory health authorities 
• Private Health Insurance Administration Council 
• Comcare  
• major workers compensation and compulsory third party motor vehicle insurers in each 
state and territory. 
Detailed descriptions of data sources and methods used in relation to all areas of 
expenditure are covered in Health expenditure Australia 2010–11 (AIHW 2012b). This includes 
a data quality statement that is also available online at 
<http://meteor.aihw.gov.au/content/index.phtml/itemId/489552>. 
The total health expenditure estimates are then allocated between Indigenous and non-
Indigenous Australians (e.g. AIHW 2013a). Detail about the methodology for doing this is 
available in Expenditure on health for Aboriginal and Torres Strait Islander people 2010–11 (AIHW 
2013a).  
Data for estimates of expenditure for disease groups and PPH are from the AIHW national 
hospital morbidity database. A data quality statement for this data is available online at        
< http://meteor.aihw.gov.au/content/index.phtml/itemId/511338>. 
The specific methodologies used to produce the analysis of expenditure by remoteness and 
disease groups are included in the relevant chapters. 
Results are often presented as a ratio of Indigenous to non-Indigenous expenditure for 
comparative purposes. Ratios over 1.0 mean that more is spent per Indigenous Australian 
than per non-Indigenous Australian, while ratios under 1.0 mean that less is spent per 
Indigenous Australian than per non-Indigenous Australian. Components in tables may not 
add due to rounding. 
Some of the expenditure patterns in this report may be influenced by variations in the 
completeness of Indigenous identification. Despite the adjustments made for under-
identification (see boxes 1 and 2), it is possible that health expenditure estimates for 
Indigenous Australians may slightly overestimate or underestimate the actual level of health 
expenditure on Indigenous Australians.  
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Structure of this report 
Chapter 2 presents estimates for health expenditure on Indigenous and non-Indigenous 
Australians by ASGC remoteness areas for admitted patient services, Office for Aboriginal 
and Torres Strait Islander Health (OATSIH) grants to Aboriginal Community Controlled 
Health Services (ACCHSs) the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits 
Scheme (PBS).  
Chapter 3 presents estimates of expenditure by disease and injury groups, for the principal 
diagnosis, for Indigenous and non-Indigenous Australians for admitted public hospital 
patient and private hospital services expenditure.  
Chapter 4 presents estimates of expenditure on Indigenous and non-Indigenous Australians 
on PPH. 
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2 Expenditure by remoteness  
This chapter examines health expenditure across the four areas of health services for which it 
was possible to estimate expenditure by remoteness:  
• admitted patient services (public and private) 
• OATSIH grants to ACCHSs 
• MBS  
• PBS.  
In 2010–11, these areas of health expenditure accounted for 61% ($2,780 million) of health 
expenditure on Indigenous Australians, compared with 65% ($77,454 million) for non-
Indigenous Australians (AIHW 2013a).  
The remaining areas of health expenditure, excluded from the analyses, accounted for 39% of 
health expenditure on Aboriginal and Torres Strait Islander people in 2010–11, and include:  
• community health services other than ACCHSs (15% of total Indigenous health 
expenditure)  
• non-admitted patient hospital services (7%) 
• patient transport (4%) 
• public health services (4%) 
• research (3%) 
• dental services (2%) 
• other MBS services (2%) 
• other health practitioners, aids and appliances, and health administration (2%).  
Because of these exclusions, care should be exercised when interpreting and/or comparing 
the estimates in this chapter with those published in Expenditure on health for Aboriginal and 
Torres Strait Islander people 2010–11 (AIHW 2013a) and earlier reports. 
Main findings 
Expenditure was allocated to the ASGC remoteness areas Major cities, Inner regional, Outer 
regional, Remote/Very remote using service use data. This showed large variation in health 
expenditure across remoteness areas in Australia. 
Overall, per person expenditure on Aboriginal and Torres Strait Islander people is higher in 
more remote areas. This difference in health expenditure could be due to the higher costs of 
delivering health care to remote populations or the greater health-care requirements of 
Indigenous people living in remote areas. While there is a large increase in per person 
expenditure on Indigenous Australians in remote areas, there is only a small increase in per 
person expenditure for non-Indigenous Australians. This suggests that patient-level factors 
are a major determinant of health expenditure in remote areas. 
The higher expenditure on Aboriginal and Torres Strait Islander people in remote areas is 
mainly due to higher expenditure on admitted patient services. PBS expenditure increases 
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slightly with remoteness and MBS expenditure decreases with remoteness. However, this 
decrease in MBS expenditure by remoteness is offset by higher expenditure on ACCHSs.  
Expenditure per person by remoteness  
For the selected categories of health expenditure on Aboriginal and Torres Strait Islander 
people that were within scope for this analysis (i.e. admitted patient services, OATSIH grants 
to ACCHSs, MBS and PBS), for every dollar spent per non-Indigenous Australian, $1.52 was 
spent on Indigenous Australians.  
Overall, there was an increase in per person health expenditure on Aboriginal and Torres 
Strait Islander people with remoteness (Table 2.1). In Major cities, expenditure was $3,899 per 
Indigenous person, while in Remote/Very remote areas it was $6,616 per Indigenous person. 
For non-Indigenous Australians, spending was similar across the remoteness areas, with per 
person expenditure decreasing slightly from $3,072 in Major cities to $2,979 in Remote/Very 
remote areas. Expenditure on non-Indigenous Australians was highest in Outer regional areas 
($3,371 per person). 
In 2010–11, expenditure per person on public hospital services on Indigenous Australians 
was higher across all areas of remoteness than expenditure per person on non-Indigenous 
Australians. For Indigenous Australians, expenditure was highest in Remote/Very remote 
regions where, for every dollar spent on non-Indigenous Australians, $2.68 was spent on 
Indigenous Australians. Health expenditure per person was also higher for Indigenous 
people in Major cities (ratio of 1.78), Inner regional areas (1.47) and Outer regional areas (1.77).  
Expenditure per person on private hospital services was lower for Indigenous Australians 
compared to non-Indigenous Australians in all remoteness areas. The Indigenous to non-
Indigenous expenditure ratio was highest in Major cities (0.66) and lowest in Outer regional 
areas (0.24).  
In Major cities, expenditure on health services delivered through ACCHSs was $330 per 
Indigenous Australian, while in Remote/Very remote areas, the per person expenditure for 
Aboriginal and Torres Strait Islander people increased to $1,256 (Table 2.1). The higher 
expenditure among Aboriginal and Torres Strait Islander people is consistent with the 
Indigenous focus of OATSIH-funded ACCHSs. 
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Table 2.1: Health expenditure per person on selected health services(a), Indigenous and 
non-Indigenous Australians, by remoteness area of patient’s residence, 2010–11 ($)  
Area of expenditure 
 
Major 
cities 
Inner 
regional 
Outer 
regional 
Remote/ 
Very 
remote 
All 
regions 
Admitted patient services   
   Public hospitals  Indigenous      2,342.3      2,358.6      3,149.2      4,683.0      3,071.6  
   Non-Indigenous      1,313.4      1,604.6      1,778.2      1,745.2      1,419.9  
   Ratio           1.78           1.47           1.77           2.68           2.16  
   Private hospitals  Indigenous         336.4         197.9           84.7           96.7         194.4  
   Non-Indigenous         508.5         482.8         359.0         301.1         486.5  
   Ratio           0.66           0.41           0.24           0.32           0.40  
OATSIH grants to ACCHS  Indigenous         329.6         435.0         569.1      1,255.8         621.5  
   Non-Indigenous             0.6             1.8             5.3           64.7             2.3  
   Ratio       564.32       243.81       106.61         19.40       266.02  
MBS
(b)
  Indigenous  567.6 514.0 396.6 224.3 467.6 
   Non-Indigenous  753.4 726.0 689.8 490.1 665.8 
   Ratio  0.75 0.71 0.58 0.46 0.70 
PBS
(c)
  Indigenous         285.2         296.2         236.4         348.6         291.3  
   Non-Indigenous         351.5         403.6         405.8         283.8         365.5  
   Ratio           0.81           0.73           0.58           1.23           0.80  
Total selected health services  Indigenous      3,899.0      3,835.3      4,459.5      6,615.8      4,675.0  
   Non-Indigenous      3,072.0      3,358.3      3,370.6      2,979.1      3,067.7  
   Ratio           1.27           1.14           1.32           2.22           1.52  
(a) Excludes health expenditure on non-admitted patient services, patient transport, dental services, community health services other than 
ACCHSs, other professional services, public health, aids and appliances, research and health administration. 
(b) Excludes allied health services, optometry and dental services. 
(c) Excludes highly specialised drugs dispensed from public and private hospitals. 
Source: AIHW health expenditure database. 
     Expenditure on health for Aboriginal and Torres Strait Islander people 2010–11  
An analysis by remoteness and disease              7 
 
Medicare Benefit Schedule and Pharmaceutical 
Benefits Scheme expenditure per person by 
remoteness 
This report uses Medicare’s Voluntary Indigenous Identifier (VII) data to estimate the MBS 
and PBS components of expenditure on health for Aboriginal and Torres Strait Islander 
people (see Box 1). Due to data limitations, the analysis by remoteness does not include 
expenditure reported as ‘Other MBS services’ in Expenditure on health for Aboriginal and Torres 
Strait Islander people 2010–11 (AIHW 2013a). As a result, there may be some variation 
between the figures presented in each report. 
Box 1: Voluntary Indigenous Identifier in MBS data 
Since 2002, Aboriginal and Torres Strait Islander people have been able to voluntarily 
identify themselves to Medicare as Indigenous. This is referred to as the Voluntary 
Indigenous Identifier (VII) program. Voluntary identification has enabled information to be 
collated on the service-use patterns of the Indigenous population, including the type of 
service used, benefit paid and fee charged, and type of pharmaceutical dispensed. 
As at June 2010, about 294,453 (52%) of the Aboriginal and Torres Strait Islander population 
had identified as Indigenous through Medicare (AIHW 2013a). This proportion varies by 
age group and sex as well as the state or territory and remoteness of the person’s residence. 
Analysis of the VII and Medicare data indicates that the benefits paid to those who identify 
as Indigenous are broadly representative of the benefits paid nationally for the Aboriginal 
and Torres Strait Islander population. 
The levels of MBS and PBS expenditure for Aboriginal and Torres Strait Islander people 
who have voluntarily identified as Indigenous have been scaled up to estimate expenditure 
for all Aboriginal and Torres Strait Islander people. These are calculated using the formula:  
Factor = 100 / percentage of VII enrolees to estimated Aboriginal and Torres Strait Islander 
resident population. 
VII data have been used in this way since the 2006–07 report in this series. The use of VII 
data provides more precise estimates of MBS and PBS expenditure, and the reliability of the 
estimates continues to increase as the level of voluntary identification rises. Nonetheless, 
comparisons over time should be interpreted with caution, as the effect of increased levels 
of voluntary identification on the Indigenous expenditure estimates has not been isolated. 
The ratio of Indigenous to non-Indigenous MBS expenditure per person varied according to 
the type of services delivered.  
In 2010–11, average MBS expenditure was $467 per Indigenous Australian and $666 per non-
Indigenous Australian, a ratio of 0.70 (Table 2.2). Per person MBS expenditure on Indigenous 
Australians decreased with remoteness, from an average of $568 per person in Major cities to 
$224 per person in Remote/Very remote areas. A similar pattern was observed for non-
Indigenous Australians. 
In 2010–11, the expenditure ratio was generally higher for unreferred MBS services (such as 
general practitioner (GP) services) than for referred MBS services (specialist and other 
tertiary services). The ratio of Indigenous to non-Indigenous expenditure for GP services 
ranged from 1.02 in Major cities to 0.54 in Remote/Very remote areas, while the ratio of other 
unreferred services ranged from 1.39 in Major cities to 0.94 in Remote/Very remote areas.   
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Table 2.2: MBS expenditure per person, Indigenous and non-Indigenous Australians, 
by remoteness area of patient’s residence, 2010–11 ($)  
MBS categories
(a)
  Major cities 
Inner 
regional 
Outer 
regional 
Remote/ 
Very remote 
All regions 
Unreferred services  
   General practitioner
(b)
 
 
   Indigenous 224.8 178.4 155.1 84.4 173.9 
   Non-Indigenous 220.2 199.1 201.8 157.3 192.5 
   Ratio 1.02 0.90 0.77 0.54 0.90 
   Other unreferred
(c)
           
   Indigenous 69.8 74.5 58.0 31.0 62.0 
   Non-Indigenous 50.1 52.1 49.5 32.9 45.2 
   Ratio 1.39 1.43 1.17 0.94 1.37 
Referred services  
    Pathology  
   Indigenous 75.0 67.2 58.8 47.2 68.3 
   Non-Indigenous 106.0 103.3 100.6 77.8 94.3 
   Ratio 0.71 0.65 0.58 0.61 0.72 
   Imaging           
   Indigenous 74.3 69.2 47.1 21.1 56.6 
   Non-Indigenous 115.5 117.6 107.8 71.2 103.2 
   Ratio 0.64 0.59 0.44 0.30 0.55 
   Specialist           
  Indigenous 48.6 42.9 23.4 7.9 33.0 
  Non-Indigenous 93.1 75.1 60.2 35.1 77.4 
  Ratio 0.52 0.57 0.39 0.22 0.43 
   Operations and other           
  Indigenous 75.2 81.7 54.3 32.7 73.6 
  Non-Indigenous 168.4 178.9 169.8 115.8 153.0 
  Ratio 0.45 0.46 0.32 0.28 0.48 
Total MBS           
 Indigenous 567.6 514.0 396.6 224.3 467.4 
 Non-Indigenous 753.4 726.0 689.8 490.1 665.7 
 Ratio 0.75 0.71 0.58 0.46 0.70 
(a) Excludes allied health services, optometry and dental services. 
(b) Includes general practitioners and vocationally registered general practitioners. 
(c)      Includes enhanced primary care, practice nurses and other unreferred services.  
Source: AIHW health expenditure database. 
For referred MBS services, Indigenous expenditure was lower than non-Indigenous 
expenditure for all services. For example, the ratio of Indigenous to non-Indigenous 
expenditure for specialist services ranged from 0.52 in Major cities to 0.22 in Remote/Very 
remote areas, with an overall ratio of 0.43. 
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In 2010–11, average PBS expenditure per person was $291 for Indigenous Australians and 
$366 for non-Indigenous Australians; a ratio of 0.80 (Table 2.3). As with MBS services, PBS 
expenditure for Aboriginal and Torres Strait Islander people varied with remoteness, 
ranging from $236 per person in Outer regional areas to $349 per person in Remote/Very remote 
areas. The ratio of Indigenous to non-Indigenous expenditure was highest in Remote/Very 
remote areas (1.23) and lowest in Outer regional areas (0.58).  
The high expenditure ratio in Remote/Very remote areas was primarily due to the PBS 
expenditure under Section 100 of the National Health Act 1953. This arrangement allows 
patients attending an approved remote area Aboriginal and Torres Strait Islander health 
service to receive PBS medicines directly from the service at no cost to the patient. 
Table 2.3: PBS expenditure per person, Indigenous and non-Indigenous 
Australians, by remoteness area of patient’s residence, 2010–11 ($)  
PBS categories
(a)
  Major cities Inner regional Outer regional 
Remote/ 
Very remote 
All regions 
Mainstream PBS benefits         
Indigenous 238.1 247.3 197.4 75.0 193.0 
Non-Indigenous 317.5 364.6 366.5 244.3 330.0 
Ratio 0.75 0.68 0.54 0.31 0.58 
Section 100           
Indigenous — — — 258.8 60.2 
Non-Indigenous — — — 13.3 0.2 
Ratio
(b)
 — — — 19.39 265.99 
Other PBS special supply         
Indigenous 47.1 48.9 39.0 14.8 38.2 
Non-Indigenous 34.0 39.0 39.3 26.2 35.3 
Ratio 1.38 1.25 0.99 0.57 1.08 
Total PBS           
Indigenous 285.2 296.2 236.4 348.6 291.3 
Non-Indigenous 351.5 403.6 405.8 283.8 365.5 
Ratio 0.81 0.73 0.58 1.23 0.80 
Total MBS and PBS
(c)
      
 Indigenous 852.9 810.1 633.1 572.8 758.8 
 Non-Indigenous 1,104.9 1,129.6 1,095.6 773.9 1,031.2 
 Ratio 0.77 0.72 0.58 0.74 0.74 
(a) Excludes highly specialised drugs dispensed from public and private hospitals.  
(b) Per person expenditure in Remote/Very remote and All regions varies due to the different populations in these regions.                         
Expenditure per person in All regions is based on the Australia-wide population. 
(c) PBS data taken from Table 2.2. 
Note:  ‘—‘ denotes nil or rounded to zero. 
Source: AIHW health expenditure database. 
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Hospital separations by remoteness 
This section compares the rates of hospital separations for Indigenous and non-Indigenous 
Australians according to the remoteness of their usual residence. While the quality of 
Indigenous identification in hospital separation data is improving, the under-identification 
of Aboriginal and Torres Strait Islander people remains an issue (see Box 1).  
The rate of hospital separations by remoteness and Indigenous status are included in this 
report to provide context to the admitted patient expenditure estimates for Aboriginal and 
Torres Strait Islander people. See Box 2 for issues with reporting hospital separations in this 
context. 
Box 2: Issues with reporting hospital separations 
Readers are advised to use the report Australian hospital statistics 2010–11 (AIHW 2012a) for 
age-standardised rates of hospital separations. In this report, rates are not age-standardised 
to ensure consistency and comparability with Expenditure on health for Aboriginal and Torres 
Strait Islander people 2010–11 (AIHW 2013a) and previous reports in that series. For more 
detail regarding issues related to age standardisation, see Chapter 5. In addition, rates of 
hospital separations in this report have been adjusted for Indigenous under-identification. 
This is not the case in Australian hospital statistics 2010–11 (AIHW 2012a). 
In 2010–11, hospital separation rates differed across remoteness areas, but were always 
higher for Indigenous Australians than for non-Indigenous Australians, particularly in 
remote areas. In Remote areas, hospital separation rates for Aboriginal and Torres Strait 
Islander people were 1,090 per 1,000 and for non-Indigenous people were 334 per 1,000. In 
Very remote areas, separation rates were 770 and 319 per 1,000 Indigenous and non-
Indigenous Australians, respectively (Table 2.4). 
Table 2.4: Hospital separation(a) rates(b), by remoteness area of patient’s residence and 
Indigenous status(c), 2010–11  
Indigenous status  Major cities 
Inner 
regional 
Outer 
regional 
Remote 
Very 
remote 
All regions 
Indigenous 521.3 487.6 736.0 1,090.0 769.6 650.7 
Non-Indigenous 396.1 435.1 400.4 334.3 319.0 402.8 
Total 397.6 436.6 421.1 450.7 534.1 409.0 
Rate ratio
(d)
 1.32 1.12 1.84 3.26 2.41 1.62 
(a) Excludes hospital separations for which care type was reported as Newborn with no qualified days, and records for Hospital boarders and 
Posthumous organ procurement. 
(b) Number per 1,000 population. 
(c) Admitted patient rates have been adjusted for Indigenous under-identification. 
(d) Indigenous to non-Indigenous rate ratio. 
Source: AIHW national hospital morbidity database. 
The difference between the Indigenous and non-Indigenous hospital separation rates (that is, 
the rate ratios) also varied across remoteness areas. The difference was greatest in Remote 
areas, with a rate ratio of 3.26, and smallest in Inner regional areas, with a rate ratio of 1.12. 
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Hospital expenditure by remoteness  
This section presents estimates of expenditure on hospital separations for Indigenous and 
non-Indigenous Australians. See Box 3 for information on adjustments for Indigenous under-
identification. Hospital expenditure is estimated according to casemix-adjusted separations, 
which account for the average complexity of patient care across hospitals. 
Average expenditure per casemix-adjusted hospital separation (hereafter referred to as 
‘separation’) for Aboriginal and Torres Strait Islander people varied across remoteness areas. 
The highest average expenditure per separation for Indigenous Australians was in Inner 
regional areas ($5,761), while the lowest expenditure was in Outer regional areas ($4,706) 
(Table 2.5). For non-Indigenous Australians, the highest expenditure was in Very remote areas 
($6,773) and the lowest was in Major cities ($4,710).  
Overall, the ratio of Indigenous to non-Indigenous expenditure was 1.06, however this 
ranged from 0.81 in Outer regional and Very remote areas to 1.12 in Major cities.  
Since 2008–09, the rate ratio for average expenditure per separation has decreased slightly 
across all remoteness areas. This change is primarily due to better identification of 
Indigenous patients in the hospital setting, which has led to fewer hospital episodes being  
re-classified as Indigenous (see Box 2 for further information on Indigenous identification in 
hospital data). The accuracy of the Indigenous health expenditure estimates continues to 
improve in line with better identification of patients in hospital-level data collections. 
Table 2.5: Average expenditure per casemix(a)-adjusted hospital(b) separation(c), by remoteness 
area of patient’s residence and Indigenous status, 2010–11 ($)
Indigenous status Major cities 
Inner 
regional 
Outer 
regional 
Remote 
Very 
remote 
All regions 
Indigenous 5,264.0  5,760.9  4,705.7  5,247.6  5,507.5  5,242.7  
Non-Indigenous 4,709.5  5,182.8  5,812.5  6,234.6  6,772.5  4,924.0  
Total 4,718.3  5,200.3  5,693.1  5,866.9  5,902.3  4,936.8  
Rate ratio
(d)
 1.12  1.11  0.81  0.84  0.81  1.06  
 (a) Casemix refers to the range and types of patients (the mix of cases) treated by a hospital or other health service. It provides a way of 
describing and comparing hospitals and other services for planning and managing health care. Casemix classifications put patients into 
manageable numbers of groups with similar conditions that use similar health-care resources, so that the activity and cost-efficiency of 
different hospitals can be compared.  
(b) The cost of private medical services funded through Medicare is not included. 
(c) Excludes hospital separations for which care type was reported as Newborn with no qualified days, and records for Hospital boarders and 
Posthumous organ procurement. 
(d) Indigenous to non-Indigenous ratio. 
Source: AIHW national hospital morbidity database. 
 
Box 3: Estimating hospital expenditure on Indigenous Australians 
In this report, admitted patient expenditure was calculated from data in the AIHW hospital 
morbidity costing model. This model applies Australian-Refined Diagnosis Related Group 
weights and length-of-stay adjustment to both Indigenous and non-Indigenous cases for 
each hospital. This model takes into account differences not only in casemix, but also in 
hospital operating costs across the regions. It also adjusts for under-identification of 
Aboriginal and Torres Strait Islander people in hospital admissions in each state and 
territory based on the study discussed below. 
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Box 3: continued 
Box 3: Estimating hospital expenditure on Indigenous Australians (continued) 
Indigenous under-identification in hospital data  
Hospital records should indicate whether an admitted patient is Aboriginal and/or Torres 
Strait Islander or non-Indigenous based on a question on the forms completed on 
admission. However, the question is not always asked or answered, and there is therefore a 
degree of under-identification of Aboriginal and Torres Strait Islander people in hospital 
records. 
In 2013, the Institute released revised under-identification factors based on a study 
conducted in 2011 and 2012. These studies are undertaken on a five-yearly basis to monitor 
identification levels over time. The level of under-identification is assessed through a data-
quality study that compares the results of face-to-face interviews where Indigenous status is 
ascertained with the information recorded in the patients’ administrative records. The 
results of this study represent the best information currently available on Indigenous under-
identification in Australian hospitals.  
Estimates of the level of Indigenous under-identification from Indigenous identification in 
hospital separation data (AIHW 2013b) have been used to adjust admitted patient 
expenditure in public hospitals. Under-identification factors can be used to estimate the 
‘true’ number of records for Indigenous people by multiplying the number of Indigenous 
people in the hospital record by the weighted correction factor. In 2010–11, under-
identification of Aboriginal and Torres Strait Islander people at the national level was 
estimated at 1.09% (AIHW 2013a). This suggests that the ‘true’ number of Indigenous 
people should be about 9% higher than indicated in the hospital record. The under-
identification factor used in 2010–11 is a lower adjustment than used in 2008, 2007 (AIHW 
2009) and 2005 (AIHW 2005b), which means that fewer hospital episodes have been 
reclassified as Indigenous. This has resulted in a slight decrease in Indigenous expenditure 
and a corresponding increase in non-Indigenous expenditure compared with the 2008–09 
report. These changes represent an improvement in the methodology and a higher degree 
of accuracy in the estimates. 
The under-identification of Indigenous Australians in public hospitals varies substantially 
between states and territories, as well as remoteness categories. In some states and 
territories, an average state-wide under-identification factor was applied to all hospital 
separations. In others, differential under-identification factors were used depending on the 
region in which particular service(s) were located.  
As the AIHW studies on Indigenous identification in hospital data did not include private 
hospitals, an adjustment factor of 54% for private hospitals was derived from the analysis of 
linked hospital morbidity data from New South Wales (AIHW: Deeble et al. 1998). 
A loading of 5% is added to the Aboriginal and Torres Strait Islander patient costs to take 
into account known differences in comorbidity for similar Diagnosis Related Groups in 
Aboriginal and Torres Strait Islander patients. This has been done in each of the 
Expenditure on health for Aboriginal and Torres Strait Islander people reports since the one 
for the 1998–99 year (AIHW 2001,  2005a, 2009, 2013a; AIHW: Deeble et al. 2008).   
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3 Expenditure by disease group 
This chapter provides expenditure estimates by disease and injury groups based on the 
principal diagnosis (only) in public hospital admitted patient services and private hospital 
services for Indigenous and non-Indigenous Australians.  
It is not possible to classify all expenditure on health goods and services by disease because 
not all expenditure can be apportioned to one specific disease or injury. The expenditure 
categories that could not be classified by disease include:  
• community health services (25% of total Indigenous health expenditure) 
• non-admitted patient hospital services (7%) 
• medical services (8%) 
• medications (5%) 
• patient transport (4%) 
• public health services (4%)  
• research (3%)  
• dental services (2%) 
• other professional services, aids and appliances, and health administration (2%) (AIHW 
2013a). 
The following limitations should be noted when interpreting the estimates: 
• they reflect 41% ($1,856 million) of total Indigenous health expenditure ($4,552 million) 
in 2010–11 (AIHW 2013a) 
• they are an indication of access to health-care services and health service use, but are not 
a measure of the size of the disease burden on the Aboriginal and Torres Strait Islander 
population 
• they do not, of themselves, provide guidance as to priorities for intervention 
• they do not, of themselves, indicate how much would be saved if a specific disease, or all 
diseases, were prevented 
• they are not an estimate of the total economic impact of diseases in the Aboriginal and 
Torres Strait Islander community. This is because the estimates do not include costs that 
are accrued outside the health system—for example, lost productivity, costs associated 
with the social and economic burden on carers and family, and costs due to lost quality 
and quantity of life. 
See Box 4 for details of the disease groupings. 
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Box 4: Disease groups 
Disease groups in this report are based on those in The burden of disease and injury in 
Australia 2003 (AIHW: Begg et al. 2007), which estimates the impact of health problems in 
Australia. In 2010–11, diagnoses and external causes of injury were recorded using the sixth 
edition of The International Statistical Classification of Diseases and Related Health Problems, 
Tenth Revision, Australian Modification (ICD-10-AM) (NCCH 2008).  
Disease and injury categories in the 2007 report were assigned to three broad cause groups:  
  •     communicable, maternal, neonatal and nutritional conditions 
  •     non-communicable diseases  
  •     injuries. 
These three broad groups were then subdivided into 22 disease groups that correspond to 
chapter-level groups of ICD-10-AM codes. These were further divided into individual 
disease and injury categories—such as asthma, hypertensive renal disease and breast 
cancer—to provide a more comprehensive coverage of the diseases reported for hospital 
admission (principal diagnosis only).  
The group ‘signs, symptoms and ill-defined conditions, and other contact with health 
services’ was included to cover some health service expenditure that could not be assigned 
to any other disease group.  
Total expenditure by disease group  
The broad disease group with the highest admitted patient expenditure for Aboriginal and 
Torres Strait Islander people was Non-communicable diseases ($1,025 million). Within this 
group, Genitourinary diseases ($195 million) accounted for the largest proportion of 
expenditure (including expenditure on dialysis treatment), followed by Mental and 
behavioural disorders ($191 million) and Cardiovascular disease ($131 million) (Table 3.1).  
The second highest broad disease group for Indigenous Australians was Communicable 
diseases, maternal, neonatal and nutritional conditions ($393 million). This includes expenditure 
of $144 million on Maternal conditions, $105 million on Acute respiratory infections and $72 
million on Neonatal causes. 
Overall, the disease groups that accounted for the highest proportion of admitted patient 
expenditure for Aboriginal and Torres Strait Islander people were Genitourinary diseases (11% 
of total admitted patient expenditure), Mental and behavioural disorders (11%), Maternal 
conditions (8%) and Unintentional injuries (8%) (Figure 3.1).  
In comparison, the disease groups that accounted for the highest proportion of admitted 
patient expenditure for non-Indigenous Australians were Cardiovascular diseases (12%), 
Unintentional injuries (10%), Musculoskeletal and connective tissue diseases (9%) and Malignant 
neoplasms (8%). 
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Source: AIHW national hospital morbidity database. 
Figure 3.1: Expenditure on hospital separations by selected disease groups and Indigenous 
status, 2010–11 
Expenditure per person by disease group 
The broad disease group with the highest per person expenditure for Aboriginal and Torres 
Strait Islander people was Non-communicable diseases ($1,801 per person), followed by 
Communicable diseases, maternal, neonatal and nutritional conditions ($691 per person), Injuries 
($348 per person) and Signs, symptoms and ill-defined conditions, and other contact with health 
services ($320 per person).  
The disease group with the highest per person expenditure ratio for Indigenous Australians 
compared with non-Indigenous Australians was Intentional injuries (ratio of 6.53) (Table 3.1). 
This was followed by Diabetes mellitus (3.33), Neonatal causes (3.26), Diseases of the skin and 
subcutaneous tissue (3.14) and Acute respiratory infections (3.10).  
The lowest per person expenditure ratio was for Malignant neoplasms (0.49), followed by 
Musculoskeletal and connective tissue diseases (0.57), Other neoplasms (0.57), Nervous system and 
sense organ disorders (0.87) and Cardiovascular disease (0.88). 
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Table 3.1: Expenditure on hospital separations(a)(b), by disease group and Indigenous status(c) in public and private hospitals, 2010–11 
Disease group 
Expenditure ($ million)  Indigenous 
share 
(per cent) 
Expenditure ($) per person 
  
Ratio  Indigenous Non-Indigenous Total Indigenous Non-Indigenous 
Communicable diseases, maternal, neonatal and nutritional 
conditions 
392.9  5,902.4  6,295.4  6.2  690.5  299.4  2.31  
  Infectious and parasitic diseases 62.4  906.7  969.1  6.4  109.6  46.0  2.38  
Sexually transmitted diseases 6.4  65.8  72.2  8.8  11.2  3.3  3.36  
Chlamydia 3.0  24.8  27.8  10.6  5.2  1.3  4.13  
Gonorrhoea 1.1  0.6  1.7  64.9  1.9  — 64.09  
Other sexually transmitted diseases
(d)
 2.4  40.4  42.7  5.5  4.1  2.0  2.02  
Diarrhoeal diseases 11.4  251.6  263.0  4.3  20.1  12.8  1.57  
Childhood immunisable diseases 0.7  9.7  10.4  6.7  1.2  0.5  2.49  
Whooping cough 0.6  8.3  8.9  7.2  1.1  0.4  2.69  
Other infectious and parasitic diseases 43.9  579.6  623.5  7.0  77.1  29.4  2.62  
  Acute respiratory infections 104.8  1,169.4  1,274.2  8.2  184.1  59.3  3.10  
Otitis media 6.2  63.0  69.1  8.9  10.8  3.2  3.39  
  Maternal conditions 144.2  2,682.8  2,827.0  5.1  253.4  136.1  1.86  
  Neonatal causes 71.9  763.2  835.1  8.6  126.3  38.7  3.26  
  Nutritional deficiencies 9.8  380.3  390.0  2.5  17.2  19.3  0.89  
Non-communicable diseases 1,024.9  27,511.7  28,536.6  3.6  1,801.1  1,395.6  1.29  
  Malignant neoplasms 48.7  3,448.0  3,496.7  1.4  85.6  174.9  0.49  
Breast cancer 2.2  161.0  163.2  1.3  3.8  8.2  0.47  
Leukaemia  4.2  223.3  227.5  1.8  7.4  11.3  0.65  
Mouth and oropharynx cancer 4.5  126.8  131.3  3.4  7.9  6.4  1.23  
Colorectal cancer 3.6  436.9  440.4  0.8  6.2  22.2  0.28  
Lung cancer 3.9  193.0  197.0  2.0  6.9  9.8  0.70  
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Table 3.1 (continued): Expenditure on hospital separations(a)(b), by disease group and Indigenous status(c) in public and private hospitals, 2010–11 
Disease group 
Expenditure ($ million) Indigenous 
share (per 
cent) 
Expenditure ($) per person 
  
Ratio  Indigenous Non-Indigenous Total Indigenous Non-Indigenous 
Non-communicable diseases (continued) 
Malignant neoplasm (continued)        
          Cervical cancer 0.7  13.3  14.0  5.1  1.2  0.7  1.84  
 
          Other malignant neoplasms 29.7  2,293.6  2,323.3  1.9  52.1  116.3  0.47  
 Other neoplasms 11.6  699.7  711.3  1.6  20.3  35.5  0.57  
 Diabetes mellitus 34.6  360.0  394.6  8.8  60.8  18.3  3.33  
          Type 2 diabetes 28.5  256.6  285.1  10.0  50.1  13.0  3.85  
  Endocrine and metabolic disorders 19.5  606.7  626.2  3.1  34.3  30.8  1.11  
  Mental and behavioural disorders 191.0  2,473.8  2,664.9  7.2  335.7  125.5  2.68  
Alcohol dependence and other harmful use 21.0  183.2  204.1  10.3  36.9  9.3  3.97  
Anxiety and depression 30.3  635.0  665.3  4.6  53.3  32.2  1.65  
  Nervous system and sense organ disorders 45.9  1,833.7  1,879.7  2.4  80.7  93.0  0.87  
Nervous system disorders 28.3  989.4  1,017.7  2.8  49.8  50.2  0.99  
Sense organ disorders 17.6  844.4  862.0  2.0  31.0  42.8  0.72  
Glaucoma-related blindness 0.2  13.6  13.8  1.5  0.4  0.7  0.53  
Cataract-related blindness 6.1  455.4  461.5  1.3  10.7  23.1  0.46  
Macular degeneration 0.3  84.4  84.7  0.4  0.5  4.3  0.12  
Adult-onset hearing loss 1.2  48.6  49.8  2.4  2.1  2.5  0.84  
Refractive disorder and other vision loss 9.8  242.5  252.3  3.9  17.3  12.3  1.40  
  Cardiovascular disease 131.0  5,170.8  5,301.8  2.5  230.1  262.3  0.88  
Rheumatic heart disease 8.0  66.7  74.7  10.7  14.0  3.4  4.15  
Ischaemic heart disease 50.9  1,633.1  1,684.0  3.0  89.4  82.8  1.08  
Stroke 16.9  681.8  698.7  2.4  29.7  34.6  0.86  
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Table 3.1 (continued): Expenditure on hospital separations(a)(b), by disease group and Indigenous status(c) in public and private hospitals, 2010–11 
Disease group 
Expenditure ($ million) Indigenous 
share (per 
cent) 
Expenditure ($) per person 
Ratio Indigenous Non-Indigenous Total Indigenous Non-Indigenous 
Non-communicable diseases (continued) 
98.8  736.4  835.2  11.8  173.7  37.4  4.7  
25.8  1,299.2  1,325.1  2.0  45.4  65.9  0.7  
50.6  700.0  750.6  6.7  89.0  35.5  2.5  
47.4  3,606.6  3,654.0  1.3  83.3  182.9  0.5  
13.6  361.4  375.0  3.6  23.9  18.3  1.3  
11.4  263.8  275.1  4.1  20.0  13.4  1.5  
142.7  4,090.8  4,233.5  3.4  250.8  207.5  1.2  
107.4  3,855.9  3,963.2  2.7  188.7  195.6  1.0  
21.1  518.0  539.1  3.9  37.0  26.3  1.4  
1.6  43.3  44.9  3.5  2.8  2.2  1.3  
24.5  1,556.3  1,580.7  1.5  43.0  78.9  0.5  
60.3  1,738.3  1,798.6  3.4  105.9  88.2  1.2  
35.3  234.9  270.3  13.1  62.1  11.9  5.2  
7.6  128.5  136.1  5.6  13.4  6.5  2.1  
27.7  105.7  133.4  20.7  48.6  5.4  9.1  
0.0  0.7  0.8  4.1  0.1  0.0  1.5  
131.2  5,227.8  5,359.1  2.4  230.6  265.2  0.9  
1,294.6  39,473.3  40,767.8  3.2  2,274.9  2,002.3  1.1  
 
98.8  736.4  835.2  11.8  173.7  37.4  4.7  
25.8  1,299.2  1,325.1  2.0  45.4  65.9  0.7  
50.6  700.0  750.6  6.7  89.0  35.5  2.5  
47.4  3,606.6  3,654.0  1.3  83.3  182.9  0.5  
13.6  361.4  375.0  3.6  23.9  18.3  1.3  
11.4  263.8  275.1  4.1  20.0  13.4  1.5  
142.7  4,090.8  4,233.5  3.4  250.8  207.5  1.2  
107.4  3,855.9  3,963.2  2.7  188.7  195.6  1.0  
21.1  518.0  539.1  3.9  37.0  26.3  1.4  
1.6  43.3  44.9  3.5  2.8  2.2  1.3  
24.5  1,556.3  1,580.7  1.5  43.0  78.9  0.5  
  Cardiovascular disease (continued)  
Inflammatory heart disease 5.7  189.6  195.2  2.9  10.0  9.6  1.04  
Peripheral vascular disease 4.5  335.4  339.9  1.3  7.9  17.0  0.47  
Other cardiovascular disease
(e)
 45.0  2,264.2  2,309.2  1.9  79.1  114.9  0.69  
Chronic respiratory disease 70.8  1,557.2  1,628.0  4.3  124.3  79.0  1.57  
Chronic obstructive pulmonary disease 32.1  596.1  628.3  5.1  56.5  30.2  1.87  
Asthma 9.8  145.5  155.3  6.3  17.2  7.4  2.33  
Other chronic respiratory diseases 28.8  815.6  844.4  3.4  50.6  41.4  1.22  
Diseases of the digestive system 105.8  3,239.4  3,345.2  3.2  186.0  164.3  1.13  
Genitourinary diseases 195.2  2,659.8  2,855.0  6.8  343.0  134.9  2.54  
Hypertensive renal disease 22.1  405.1  427.2  5.2  38.8  20.6  1.89  
          Other nephritis and nephrosis
(f)
 137.3  815.6  952.9  14.4  241.2  41.4  5.83  
Other genitourinary diseases 35.9  1,439.0  1,474.9  2.4  63.1  73.0  0.86  
  Diseases of the skin and subcutaneous tissue 70.3  775.3  845.6  8.3  123.6  39.3  3.14  
  Musculoskeletal and connective tissue diseases 65.8  3,994.7  4,060.5  1.6  115.7  202.6  0.57  
  Congenital anomalies 18.9  400.3  419.2  4.5  33.3  20.3  1.64  
  Oral conditions 15.8  292.2  307.9  5.1  27.7  14.8  1.87  
Injuries
(g)
 198.2  4,531.0  4,729.2  4.2  348.3  229.8  1.52  
  Unintentional injuries 149.1  4,270.8  4,419.9  3.4  262.0  216.6  1.21  
Road traffic and other transport accidents 29.2  573.8  603.0  4.8  51.4  29.1  1.77  
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Table 3.1 (continued): Expenditure on hospital separations(a)(b), by disease group and Indigenous status(c) in public and private hospitals, 2010–11 
Disease group 
Expenditure ($ million) Indigenous 
share (per 
cent) 
Expenditure ($) per person 
Ratio 
Indigenous Non-Indigenous Total Indigenous 
Non-
Indigenous 
Unintentional injuries (continued)        
Poisoning 2.2  48.0  50.1  4.4  3.8  2.4  1.58  
Falls 34.0  1,723.7  1,757.7  1.9  59.7  87.4  0.68  
Other unintentional injuries 83.7  1,925.3  2,009.0  4.2  147.1  97.7  1.51  
  Intentional injuries 49.1  260.2  309.3  15.9  86.2  13.2  6.53  
Self-inflicted injuries 10.6  142.3  152.9  6.9  18.7  7.2  2.58  
Injuries inflicted by another person 38.5  117.9  156.4  29.7  67.6  6.0  13.20  
Signs, symptoms and ill-defined conditions, and  
other contact with health services
(h)
 
182.2  5,790.4  5,972.7  3.1  320.2  293.7  1.09  
Total 1,798.3  43,735.5  45,533.9  3.9  3,160.1  2,218.5  1.42  
(a) Includes hospital separation data for all states/territories. 
(b) Excludes hospital separations for which care type was reported as Newborn with no qualified days, and records for Hospital boarders and Posthumous organ procurement. 
(c) Admitted patient rates have been adjusted for Indigenous under-identification.  
(d) Includes HIV/AIDS, hepatitis B, syphilis and other sexually transmitted diseases. 
(e) Includes hypertensive heart disease, aortic aneurysm and dissection, non-rheumatic heart disease and other cardiovascular disease. 
(f) Includes expenditure for care involving dialysis. 
(g) Hospital separations resulting from external cause events treated during hospitalisations. 
(h) ‘Signs, symptoms and ill-defined conditions’ include diagnostic and other services for signs, symptoms and ill-defined conditions where the cause of the problem is unknown. ‘Other contact with health services’ 
includes fertility control, reproduction and development; elective cosmetic surgery; general prevention, screening and health examination; and treatment and after-care for unspecified disease. 
Source: AIHW national hospital morbidity database
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4 Expenditure by potentially preventable 
hospitalisations 
This chapter presents estimates of expenditure on potentially preventable hospitalisations 
(PPH). PPH are conditions where hospitalisation is thought to have been avoidable, 
primarily if more timely and adequate care had been provided through other parts of the 
health system. See Box 5 for more information on the classification of PPH. 
It is useful to examine expenditure on PPH for Indigenous and non-Indigenous Australians 
to gain some insight into health cost burdens that might have been reduced through more 
effective care. A high level of PPH expenditure, however, may reflect such things as 
increased prevalence of illness within the community leading to higher demand for health 
care. 
In 2010–11, total expenditure on PPH for Aboriginal and Torres Strait Islander people was 
$219 million, or $385 per Indigenous person (Table 4.1). In comparison, non-Indigenous 
expenditure on PPH was $3,420 million, or $174 per non-Indigenous person. Further detail is 
provided below.  
PPH expenditure by disease group 
The highest PPH expenditure category for Aboriginal and Torres Strait Islander people was 
Chronic conditions, which accounted for $115 million. A large proportion of this expenditure 
was due to chronic obstructive pulmonary disease ($36 million) and diabetes complications 
($35 million) (Table 4.1).  
Expenditure on Indigenous Australians for Acute conditions was $93 million, which included 
cellulitis ($20 million), convulsions and epilepsy ($20 million) and pyelonephritis ($15 
million). 
Vaccine-preventable conditions accounted for $12 million of Indigenous expenditure, of which 
$11 million was attributed to influenza and pneumonia. 
PPH expenditure per person by disease group 
In 2010–11, per person expenditure on Indigenous Australians was much higher than non-
Indigenous Australians for all categories of PPH (Figure 4.1).  
Overall, Chronic conditions had the highest level of per person expenditure for both 
Indigenous Australians ($202 per person) and non-Indigenous Australians ($98 per person) 
(Table 4.1). For Indigenous Australians within this category, chronic obstructive pulmonary 
disease accounted for the highest per person expenditure ($63 per Indigenous Australian 
compared with $31 per non-Indigenous Australian), followed by diabetes complications ($61 
per Indigenous Australian and $18 per non-Indigenous Australian). For all chronic 
conditions, the ratio of Indigenous to non-Indigenous expenditure was 2.06. 
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Box 5: Classification of potentially preventable hospitalisations (PPH) 
This report uses three broad categories of PPH, which have been sourced from The Victorian 
Ambulatory Care Sensitive Conditions Study (DHS 2002) and are classified as: 
Vaccine-preventable—these diseases can be prevented by proper vaccination and include 
influenza, bacterial pneumonia, tetanus, measles, mumps, rubella, pertussis and polio. 
These conditions are considered to be preventable and, therefore, hospitalisations are 
considered preventable. 
Acute—these conditions may not be preventable, but theoretically would not have resulted 
in hospitalisation if adequate and timely care (usually primary health and/or outpatient 
care) was received. These include complicated appendicitis, dehydration/gastroenteritis, 
pyelonephritis, perforated ulcer, cellulitis, pelvic inflammatory disease, ear nose and throat 
infections, and dental conditions. 
Chronic—these conditions may be preventable through behaviour modification and 
lifestyle change, but they can also be managed effectively through timely care to prevent 
deterioration and hospitalisation. These conditions include diabetes complications, asthma, 
angina, hypertension, congestive heart failure and chronic obstructive pulmonary disease. 
Although the general concepts and classification of PPH used in this report are similar to 
those used in Australian hospital statistics 2010–11 (AIHW 2012a), the methodology used to 
derive PPH expenditure separations differs substantially from the one used to derive PPH 
separations. In order to estimate expenditure on PPH, only the principal diagnosis is used. 
In other AIHW publications that include discussion of PPH, additional diagnoses are also 
taken into account. This is not done with respect to expenditure as there is no methodology 
for allocating expenditure against a number of diagnoses occurring during the same 
hospitalisation. As expenditure estimates apply only to the principal diagnosis, they are 
likely to underestimate the cost of PPH.  
The estimates have been adjusted for Indigenous under-identification and are crude rather 
than age-standardised rates. This is to ensure consistency and comparability with data in 
the series, including the most recent report Expenditure on health for Aboriginal and Torres 
Strait Islander people 2010–11 (AIHW 2013a). 
The Acute conditions category had the second highest level of per person expenditure ($163 
per Indigenous Australian and $71 per non-Indigenous Australian). For Indigenous 
Australians, cellulitis had the highest per person expenditure ($36 per person) followed by 
convulsions and epilepsy ($35 per person) and pyelonephritis ($26 per person). The overall 
ratio of Indigenous to non-Indigenous expenditure for acute conditions was 2.30. 
Expenditure on Vaccine-preventable conditions was $21 per Indigenous Australian and $5 per 
non-Indigenous Australian. Within this category, per person expenditure on pneumonia and 
influenza was higher for Indigenous Australians ($19 per person) compared with non-
Indigenous Australians ($4 per person); a ratio of 4.47. Under the Immunise Australia 
Program, free vaccines are available for Aboriginal and Torres Strait Islander people 15 years 
and older and to children with a pre-existing medical condition. These are provided through 
ACCHSs, state and territory immunisation clinics, and general practitioners (DoHA 2013).  
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Table 4.1: Expenditure on potentially preventable hospital separations(a) by Indigenous status in public and private hospitals, 2010–11 
PPH category 
Total expenditure ($ million) Indigenous share 
(per cent) 
Expenditure per person ($) 
Ratio Indigenous Non-Indigenous Total Indigenous Non-Indigenous 
Vaccine-preventable conditions        
     Influenza and pneumonia 11.0 85.0 95.9 11.4 19.3 4.3 4.47 
     Other vaccine-preventable conditions 0.9 13.4 14.3 6.5 1.6 0.7 2.40 
Total vaccine-preventable conditions 11.9 98.3 110.2 10.8 20.9 5.0 4.19 
Acute conditions               
     Appendicitis with generalised peritonitis — — — — — — — 
     Cellulitis 20.2 289.5            309.7  6.5 35.5 14.7 2.42 
     Convulsions and epilepsy 19.7 176.1            195.7  10.0 34.5 8.9 3.87 
     Dehydration and gastroenteritis 8.7 226.2            234.9  3.7 15.3 11.5 1.33 
     Dental conditions 13.1 135.9            149.0  8.8 23.1 6.9 3.35 
     Ear, nose and throat infections 10.9 108.8            119.7  9.1 19.2 5.5 3.48 
     Gangrene 0.6 7.2                 7.8  8.1 1.1 0.4 3.04 
     Pelvic inflammatory disease 2.5 18.9              21.4  11.6 4.4 1.0 4.56 
     Perforated/ bleeding ulcer 1.7 69.6              71.3  2.4 3.1 3.5 0.87 
     Pyelonephritis 14.9 362.6            377.6  4.0 26.3 18.4 1.43 
Total acute conditions 92.5 1,394.7        1,487.1  6.2 162.5 70.7 2.30 
Chronic conditions              
     Angina 5.2 112.2            117.3  4.4 9.1 5.7 1.60 
     Asthma 9.8 143.8            153.6  6.4 17.2 7.3 2.36 
    Chronic obstructive pulmonary disease 35.9 619.6            655.5  5.5 63.1 31.4 2.01 
    Congestive heart failure 16.9 510.5            527.4  3.2 29.7 25.9 1.15 
    Diabetes complications 34.5 359.1            393.6  8.8 60.6 18.2 3.33 
    Hypertension 1.8 32.4              34.2  5.2 3.1 1.6 1.91 
    Iron deficiency anaemia 2.2 77.5              79.7  2.8 3.9 3.9 0.98 
    Nutritional deficiencies
(b)
 0.5 5.6                 6.1  8.5 0.9 0.3 3.22 
    Rheumatic heart disease 8.0 66.7              74.7  10.7 14.0 3.4 4.15 
Total chronic conditions 114.8 1,927.4        2,042.2  5.6 201.8 97.8 2.06 
Total 219.2 3,420.4        3,639.5  6.0 385.1 173.5 2.22 
(a) Includes hospital separations data for all states/territories. Hospital separation rates differ from those published in Australian hospital statistics: 2010–11 (AIHW 2012a) because the estimates in this report  
relate to principal diagnoses only, have been adjusted for Indigenous under-identification and are crude rates (rather than age-standardised rates). 
(b) This condition is a subset of the burden of disease and injury group Nutritional deficiencies and cannot be compared with data in Table 3.1. 
Note:   ‘—‘ denotes nil or rounded to zero. 
Source: AIHW national hospital morbidity database.
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Source: AIHW national hospital morbidity database.  
Figure 4.1: Expenditure on hospital separations for potentially preventable hospitalisations (PPH) 
by Indigenous status, 2010–11 
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